-
Innovation Ranking
NewInnovation Ranking – GMO Internet, Inc.
GMO Internet Group Inc (GMO Internet), formerly GMO Internet Inc, provides internet services. The company's various business includes internet infrastructure, online advertising and media, internet finance, and cryptoassets divisions. The internet infrastructure provides services including web hosting, domain registration, payment processing, internet security, and e-commerce tools. The company's online advertising and media business comprises online advertising and search engine marketing. The internet finance business provides securities trading, and FX trading services. Its cryptoassets business offers crypto asset trading service and...
-
Company Insights
Innovation and Patenting activity of GMO Cloud K.K. Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of GMO Cloud K.K. Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
Innovation and Patenting activity of GMO Internet Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of GMO Internet Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
Innovation and Patenting activity of Gmo Payment Gateway Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Gmo Payment Gateway Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Track & Monitor
Environment sustainability in oil & gas: bioethanol production GMOs
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the oil & gas industry’s bioethanol production GMOs segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FB-001 in Secondary Hyperoxaluria
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.FB-001 in Secondary HyperoxaluriaDrug Details:FB-001 is under development for the treatment of secondary hyperoxaluria. The drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-2487 in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-2487 in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-2487 in Rheumatoid Arthritis Drug Details: R-2487 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – T-3PY058739 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - T-3PY058739 in Solid Tumor report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SYNB-1618 in Phenylketonuria (PKU)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SYNB-1618 in Phenylketonuria (PKU) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SYNB-1618 in Phenylketonuria (PKU) Drug Details:SYNB-1618 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-3750 in Ulcerative Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-3750 in Ulcerative Colitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.R-3750 in Ulcerative ColitisDrug Details: R-3750 is under development for the treatment of...